San Clemente-based BioLase Technology Inc. said Monday that it expects fourth-quarter revenue to be higher than expected.
The maker of lasers for root canal and dental surgeries said it expects sales of about $19 million in the period, higher than the average analyst forecast of $17.1 million.
BioLase didn’t say in a release what spurred the improved outlook.
Shares of BioLase were up 10.3% to $8.78 in trading on Monday.
